Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CVD Equipment Corporation | 0V3 | Nov 15, 2024 | 2.92 | +13.18 |
CVR Energy Inc | FL9 | Nov 15, 2024 | 17.75 | +0.77 |
CVS Group Plc | 4C9 | Nov 15, 2024 | 9.95 | +1.02 |
CVS HEALTH CDR(REG.S) | CVS0 | Nov 15, 2024 | 8.80 | +0.57 |
CVS Health Corporation | CVS | Nov 15, 2024 | 50.67 | -2.93 |
CVW CLEANTECH INC. | TMD0 | Nov 15, 2024 | 0.56 | -1.77 |
CY4GATE S.P.A. | 68H | Nov 15, 2024 | 3.88 | -1.90 |
Cyan AG | CYR | Nov 15, 2024 | 2.64 | 0.00 |
CyanConnode Holdings Plc | CUAN | Nov 15, 2024 | 0.10 | 0.00 |
Cyber Security 1 | 7CS | Nov 15, 2024 | 0.01 | 0.00 |
CyberAgent,Inc. | CL2 | Nov 15, 2024 | 5.90 | 0.00 |
CyberArk Software Ltd. - Ordinary Shares | CYB | Nov 15, 2024 | 281.70 | -1.40 |
CyberCatch Global | D0K | Nov 15, 2024 | 0.04 | 0.00 |
Cyberdyne Inc | 8C4 | Nov 15, 2024 | 1.00 | -9.40 |
CYBEROO S.P.A. | K97 | Nov 15, 2024 | 2.04 | -0.97 |
CYBERTRUST JAPAN | 5U2 | Nov 15, 2024 | 13.70 | +5.38 |
Cybin | R7E | Nov 15, 2024 | 11.10 | 0.00 |
Cyfrowy Polsat SA | CP9 | Nov 15, 2024 | 2.61 | +0.77 |
Cymbria Corp | CYOA | Nov 15, 2024 | 51.00 | 0.00 |
CYNATA THERAPEUTICS LTD Ordinary Shares(Australia) | 51S | Nov 15, 2024 | 0.14 | +4.65 |
Cytokinetics, Incorporated | KK3A | Nov 15, 2024 | 47.40 | -8.85 |
Cytomed Therapeutics | F98 | Nov 15, 2024 | 1.93 | -4.46 |
CytomX Therapeutics, Inc. | 6C1 | Nov 15, 2024 | 0.88 | +2.03 |
CYTOPHAGE TECHN. LTD. | 70G | 0.00 | 0.00 | |
Cytosorbents Corporation | HQE1 | Nov 15, 2024 | 0.86 | +1.06 |
Cyviz | 8P9 | Nov 15, 2024 | 2.37 | -2.87 |
Cyxone | 4CX | Nov 15, 2024 | 0.00 | 0.00 |
CZG - Ceska Zbrojovka Group SE | 6QS | Nov 15, 2024 | 24.70 | -2.76 |
D Amico International Shipping | B7C0 | Nov 15, 2024 | 4.39 | -1.24 |
D-Box Technologies Inc. | DB2 | Nov 15, 2024 | 0.06 | -5.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.